There are multiple prophylactic or curative addresses to SARS COVID-19 that are banned or eschewed by the medical mafia and the government cartel as they cut across big pharma’s profits. Ivermectin is one such.<\/p>\n
A study on the efficacy of ivermectin in the Journal of Biomedical Research and Clinical Investigations reported that not one person of the 788 people taking Ivermectin prophylactically tested positive for SARS-CoV-2. However, during the same period, 58% of the 407 participants not taking ivermectin were diagnosed with COVID-19.<\/p>\n
Another study involving Professor Thomas Borody showed that \u201civermectin is a safe, inexpensive and effective early COVID-19 treatment validated in 20+ RCTs (randomised controlled trials)\u201d and that \u201csuccessful treatment was reached for all subjects\u201d. No patient who accepted treatment required hospitalisation.<\/p>\n
Emeritus Professor Robert Clancy has stated that we should \u201cimmediately establish safe and effective early treatment\u201d protocols based on \u201coverwhelming science\u201d that include hydroxychloroquine and Ivermectin, and that these treatments save lives.<\/p>\n
The Monash Biomedicine Discovery Institute showed that ivermectin stopped SARS-CoV-2 from growing in a cell culture within 48 hours. The evidence is unequivocal. Ivermectin is a readily available drug, it is safe and it is effective in the early treatment of COVID-19.<\/p>\n
Why is ivermectin not being used as part of the early treatment protocol for COVID-19 in Australia?<\/p>\n","protected":false},"excerpt":{"rendered":"
There are multiple prophylactic or curative addresses to SARS COVID-19 that are banned or eschewed by the medical mafia and the government cartel as they cut across big pharma’s profits. Ivermectin is one such. A study on the efficacy of ivermectin in the Journal of Biomedical Research and Clinical Investigations reported that not one person … <\/p>\n